Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic literature review that examined pregnancy after BC, fetal and obstetrical outcomes, disease-free survival (DFS), and overall survival (OS). Data were included from 39 studies with 57,739 women with cancers other than BC and 114,573 women with BC. The researchers found that 7,505 patients with BC had a pregnancy after their diagnosis. Patients with BC had lower chances of having a pregnancy following anticancer treatment completion compared with women from the general population (relative risk, 0.40). BC survivors had significantly increased risks of low birth weight, small for gestational age, preterm delivery, and cesarean section compared with the general population (odds ratios, 1.50, 1.16, 1.45, and 1.14, respectively). However, no negative impacts were observed on patient outcomes in association with pregnancy after BC. Better OS and DFS were seen for patients with BC with subsequent pregnancy versus those without (hazard ratios [HRs], 0.56 and 0.73, respectively). The results were similar after adjustment for the “healthy mother effect” (HRs for OS and DFS, 0.52 and 0.74, respectively).
May 27, 2020
June 14, 2019
ACEP20: Despite Increased Stress Due to COVID-19, Nearly Half of ED Physicians Fear Seeking Mental Healthcare
October 30, 2020
December 23, 2020
- SABCS 2020The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS®) will take place from December 8-11, 2020. The SABCS is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known for presenting the latest breast cancer data from all over the world.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.